Two different problems
Pattern hair loss is a two-part story. DHT, a byproduct of testosterone, gradually shrinks genetically sensitive follicles until they produce only fine, short hairs. Meanwhile each follicle’s growth phase shortens, so hair spends more time resting than growing. Finasteride addresses the first part; minoxidil the second.
How finasteride protects
Finasteride blocks 5-alpha-reductase, the enzyme that converts testosterone to DHT, lowering scalp DHT substantially. The 1 mg oral tablet is FDA-approved for male pattern hair loss. Less DHT means less miniaturization – it protects the follicles you still have, which is why starting earlier tends to preserve more.
How minoxidil grows
Minoxidil widens small blood vessels and lengthens the anagen (growth) phase, coaxing resting follicles back to work and thickening the hairs they produce. Topical minoxidil is FDA-approved over the counter. It does not touch DHT – which is exactly why the two medicines pair logically rather than redundantly.
Finasteride is FDA-approved as a brand product for androgenetic alopecia in men.
The shedding surprise
A few weeks in, minoxidil often causes a brief increase in shedding. It looks alarming and is usually the opposite: resting hairs being pushed out by new growth underneath. Most regimens are judged at three to six months, not three weeks.
Compounded combinations
Some prescriptions combine these medicines – a topical solution carrying both, or an oral capsule adding biotin. Those combinations are compounded medications: not FDA-approved, and not reviewed by FDA for safety, effectiveness, or quality before marketing. A licensed clinician prescribes them only when the combination fits the specific patient.
What a clinician weighs
Age, pattern, family history, how fast the loss is moving, and your tolerance for daily routines versus tablets. Sexual side effects with finasteride are uncommon but real and worth an honest conversation. All of it is exactly what the telehealth intake and clinician review are for. See the 30-second film answers for this medication.
Two different mechanisms, two different jobs
Androgenetic hair loss is driven substantially by dihydrotestosterone, or DHT, which miniaturises genetically susceptible follicles over time. Finasteride inhibits 5-alpha-reductase, the enzyme that converts testosterone to DHT, which addresses the driver. Minoxidil does something unrelated: it is a vasodilator and potassium channel opener that appears to extend the anagen, or growth, phase of the follicle cycle. Because the mechanisms are independent, they are frequently used together, and that combination is the basis of most treatment plans. According to FDA prescribing information, oral finasteride 1 mg and topical minoxidil are both approved for androgenetic alopecia; oral minoxidil for hair loss is prescribed off-label. Topical versus oral finasteride covers the delivery question.
Why nothing visible happens for months
The follicle cycle sets the pace, and it cannot be rushed. Hair grows for years, rests for weeks, sheds, and regrows, so any intervention that acts on the cycle needs a full cycle to become visible. Clinical trials of both finasteride and minoxidil generally assess results at three to six months and again at twelve. Early on, minoxidil commonly causes a temporary increase in shedding as resting follicles are pushed into a new growth phase; that is expected rather than a failure. Stopping either medication returns the follicle to its untreated trajectory, so these are maintenance treatments, not cures. How long minoxidil takes sets realistic expectations. Individual results vary and no result is guaranteed.
The side effects worth understanding before you start
Finasteride’s label lists sexual adverse effects including decreased libido and erectile dysfunction, reported at low single-digit percentages in trials, generally reversible on discontinuation. There are also post-marketing reports of persistent effects and of mood changes, which is why this is a conversation to have with a clinician rather than a footnote. Finasteride is contraindicated in pregnancy: it can affect development of male genitalia, so anyone who is or may become pregnant should not handle broken tablets. Minoxidil topically can cause scalp irritation and unwanted facial hair growth; oral minoxidil, used off-label, can cause fluid retention and cardiovascular effects and needs clinician oversight. A licensed clinician decides whether either is appropriate for you.
Your intake goes to a licensed clinician, not an algorithm.
Frequently asked questions
How long does minoxidil take to work?
Hair cycles are slow, so assessment periods are measured in months. Your clinician sets expectations at follow-up rather than promising a date.
Does minoxidil work?
FDA approved topical minoxidil for androgenetic alopecia. Response varies between individuals, and no specific outcome is guaranteed for any one person.
Can minoxidil cause hair loss?
An early shedding phase is described in patient information for minoxidil as existing hairs are replaced. Report anything concerning to your clinician.
How do minoxidil and finasteride differ?
According to FDA labeling, finasteride inhibits 5-alpha reductase and reduces conversion of testosterone to DHT. Minoxidil is a vasodilator that affects the hair growth cycle. Different targets.
Can they be used together?
Some clinicians prescribe both. Whether that is appropriate for you is a clinical decision after evaluation.
Does finasteride regrow hair?
Finasteride inhibits the conversion of testosterone to DHT, which addresses a driver of androgenetic hair loss. Trials assess results at three to six months and again at twelve. Individual results vary and no result is guaranteed.
What if the answer is yes?
Ten minutes now, and a licensed clinician tells you where you actually stand.
Rx only. A licensed clinician decides whether treatment is appropriate and may determine that no treatment, or a different treatment, is right for you. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Individual results vary.
Sources
Clinical trials listed below evaluated FDA-approved products at the doses studied. They are cited as published science, not as evidence about any compounded preparation, which is not FDA-approved and has not been evaluated by FDA for safety, effectiveness, or quality.
- FDAFDA: PROPECIA (finasteride) prescribing information
- FDA databaseFDA: ROGAINE (minoxidil topical) drug information
- NIH MedlinePlusMedlinePlus: Minoxidil topical
- NIHMedlinePlus: Androgenetic alopecia
Spotted something inaccurate? Report an error – corrections are logged per our editorial standards.
More on Hair Loss
Same medication, different question.
